These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis. Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007 [TBL] [Abstract][Full Text] [Related]
3. [Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis]. Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Kazubskaya TP; Kushlinsky DN; Ermilova VD; Rykov SV; Khodyrev DS; Braga EA Mol Biol (Mosk); 2018; 52(5):801-809. PubMed ID: 30363055 [TBL] [Abstract][Full Text] [Related]
4. [A Group of Hypermethylated miRNA Genes in Breast Cancer and Their Diagnostic Potential]. Filippova EA; Loginov VI; Pronina IV; Khodyrev DS; Burdennyya AM; Kazubskaya TP; Braga EA Mol Biol (Mosk); 2019; 53(3):421-429. PubMed ID: 31184607 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma. Braga EA; Loginov VI; Filippova EA; Burdennyi AM; Pronina IV; Kazubskaya TP; Khodyrev DS; Utkin DO; Kushlinskii DN; Adamyan LV; Kuslinskii NE Bull Exp Biol Med; 2018 Dec; 166(2):253-256. PubMed ID: 30488208 [TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of methylation of a group of miRNA genes in patients with ovarian cancer.]. Kushlinskii NE; Utkin DO; Loginov VI; Filippova EA; Burdennyy AM; Kushlinsky DN; Pronina IV; Braga EA Klin Lab Diagn; 2020; 65(5):321-327. PubMed ID: 32298550 [TBL] [Abstract][Full Text] [Related]
16. E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness. Cheng FHC; Lin HY; Hwang TW; Chen YC; Huang RL; Chang CB; Yang W; Lin RI; Lin CW; Chen GCW; Mai SY; Lin JMJ; Chuang YM; Chou JL; Kuo LW; Li C; Cheng ASL; Lai HC; Wu SF; Tsai JC; Chan MWY Cancer Sci; 2019 Mar; 110(3):1085-1095. PubMed ID: 30582655 [TBL] [Abstract][Full Text] [Related]
17. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer. Schmid G; Notaro S; Reimer D; Abdel-Azim S; Duggan-Peer M; Holly J; Fiegl H; Rössler J; Wiedemair A; Concin N; Altevogt P; Marth C; Zeimet AG BMC Cancer; 2016 Feb; 16():102. PubMed ID: 26879132 [TBL] [Abstract][Full Text] [Related]
18. The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma. He XX; Kuang SZ; Liao JZ; Xu CR; Chang Y; Wu YL; Gong J; Tian DA; Guo AY; Lin JS Mol Biosyst; 2015 Feb; 11(2):532-9. PubMed ID: 25424171 [TBL] [Abstract][Full Text] [Related]
19. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer. Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357 [TBL] [Abstract][Full Text] [Related]
20. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]